HomeMarket NewsMicro Cap StocksAI To Revolutionize Clinical Trials And Diagnostics

AI To Revolutionize Clinical Trials And Diagnostics

Actionable Trade Ideas

always free

female scientist lab with notepad

The pharmaceutical industry is leveraging technology to gain valuable insights that propel the development of the next generation of drugs, expedite clinical trials, and enhance diagnostics. For instance, Mainz Biomed MYNZ has introduced ColoAlert, an affordable test for early detection of Colorectal cancer. Mainz Biomed, which specializes in molecular genetic diagnostic solutions for life-threatening conditions, has also partnered with Microba Life Sciences. Together, they aim to discover disease-specific microbiome biomarkers to improve the development of PancAlert. Clinical trials, however, can be expensive, time-consuming, and data-intensive, making the acceleration of this process a game-changer. This is where AI comes into play. ​​​​​​

AI’s Role in Accelerating Clinical Trials and Reducing Costs

From 2016 to 2022, the U.S. Food and Drug Administration received approximately 300 applications utilizing AI for drug development. The majority, over 90%, were submitted in the past two years, with a focus on AI’s potential during clinical trials.

Leading pharmaceutical companies are leveraging this emerging technology to swiftly identify suitable patients for clinical trials and decrease the required sample size. By doing so, they accelerate drug and treatment development while reducing costs. Examples include Amgen Inc AMGN, Bayer Aktiengesellschaft BAYRY, and Novartis AG NVS. These companies employ AI to scan public health records, prescription data, medical insurance claims, and internal data. In certain cases, AI has successfully reduced the time required for this process by half. Blythe Adamson, senior principal scientist at Roche Holding RHHBY subsidiary Flatiron Health, explained that AI enables faster examination of real-world patient data at a large scale, transforming tasks that previously took months into mere days.

AI’s Advancements in Cancer Diagnostics

GlobalData predicts that within the next decade, more manufacturers of in-vitro diagnostic devices will integrate AI to enhance diagnostic and treatment predictions, as well as streamline oncologists’ workflows. Consequently, more cancer patients will receive life-saving treatments in earlier stages, aided by AI’s ability to determine the most effective treatments. Pioneering initiatives like the one undertaken by Mainz Biomed have the potential to be life-changing for many individuals, particularly in the field of early cancer detection.

The Risks Associated with AI

The potential of AI to accelerate data ingestion and interpretation is tremendous. However, the technology’s effectiveness relies heavily on the quality of the data it learns from. Hence, scientific expertise is crucial. Mainz Biomed takes this approach seriously by placing scientific know-how at the core of its operations and establishing strategic partnerships, such as the recent collaboration with Γ„rztliches Labor Dr. Buhlman. This strategy enhances Mainz Biomed’s pioneering products with the necessary expertise. In fact, the latest clinical trial data exceeded expectations, demonstrating high sensitivity in detecting colorectal cancer and advanced adenoma. It is vital to utilize AI to increase the efficiency of scientific research while maintaining careful judgment, as inaccurate or incomplete data may lead to incorrect conclusions and the dissemination of false information. When used cautiously and precisely, AI will undoubtedly revolutionize diagnostics, saving valuable time and costs.

DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.